Cargando…
Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2
BACKGROUND: Italy experienced one of the world’s severest COVID-19 outbreak, with Lombardy being the most afflicted region. However, the imposed safety measures allowed to flatten the epidemic curve and hence to ease the restrictions and inaugurate, on the 4th of May 2020, the Italian phase (P) 2 of...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641253/ https://www.ncbi.nlm.nih.gov/pubmed/33150476 http://dx.doi.org/10.1007/s12032-020-01434-1 |
_version_ | 1783605881122848768 |
---|---|
author | Jereczek-Fossa, Barbara Alicja Pepa, Matteo Marvaso, Giulia Isaksson, Johannes Lars Soatti, Carlo Pietro Cazzaniga, Luigi Franco Ivaldi, Giovanni Battista Amadori, Marcello Antognoni, Paolo Arcangeli, Stefano Buffoli, Alberto Beltramo, Giancarlo Bignardi, Mario Bracelli, Stefano Bruschieri, Lorenza Castiglioni, Simona Catalano, Gianpiero Di Muzio, Nadia Fallai, Carlo Fariselli, Laura Filippi, Andrea Riccardo Gramaglia, Alberto Italia, Corrado Lombardi, Fabrizio Magrini, Stefano Maria Nava, Simonetta Orlandi, Ester Pasinetti, Nadia Sbicego, Elena Lara Scandolaro, Luciano Scorsetti, Marta Stiglich, Francesco Tortini, Roberto Valdagni, Riccardo Vavassori, Vittorio Tonoli, Sandro Palazzi, Mauro Filippo |
author_facet | Jereczek-Fossa, Barbara Alicja Pepa, Matteo Marvaso, Giulia Isaksson, Johannes Lars Soatti, Carlo Pietro Cazzaniga, Luigi Franco Ivaldi, Giovanni Battista Amadori, Marcello Antognoni, Paolo Arcangeli, Stefano Buffoli, Alberto Beltramo, Giancarlo Bignardi, Mario Bracelli, Stefano Bruschieri, Lorenza Castiglioni, Simona Catalano, Gianpiero Di Muzio, Nadia Fallai, Carlo Fariselli, Laura Filippi, Andrea Riccardo Gramaglia, Alberto Italia, Corrado Lombardi, Fabrizio Magrini, Stefano Maria Nava, Simonetta Orlandi, Ester Pasinetti, Nadia Sbicego, Elena Lara Scandolaro, Luciano Scorsetti, Marta Stiglich, Francesco Tortini, Roberto Valdagni, Riccardo Vavassori, Vittorio Tonoli, Sandro Palazzi, Mauro Filippo |
author_sort | Jereczek-Fossa, Barbara Alicja |
collection | PubMed |
description | BACKGROUND: Italy experienced one of the world’s severest COVID-19 outbreak, with Lombardy being the most afflicted region. However, the imposed safety measures allowed to flatten the epidemic curve and hence to ease the restrictions and inaugurate, on the 4th of May 2020, the Italian phase (P) 2 of the pandemic. The present survey study, endorsed by CODRAL and AIRO-L, aimed to assess how radiotherapy (RT) departments in Lombardy have dealt with the recovery. MATERIALS AND METHODS: A questionnaire dealing with the management of pandemic was developed online and sent to all CODRAL Directors on the 10th of June 2020. Answers were collected in full anonymity one week after. RESULTS: All the 33 contacted RT facilities (100%) responded to the survey. Despite the scale of the pandemic, during P1 14 (42.4%) centres managed to safely continue the activity (≤ 10% reduction). During P2, 10 (30.3%) centres fully recovered and 14 (42.4%) reported an increase. Nonetheless, 6 (18.2%) declared no changes and, interestingly, 3 (9.1%) reduced activities. Overall, 21 centres (63.6%) reported suspected or positive cases within healthcare workforce since the beginning of the pandemic. Staff units were quarantined in 19 (57.6%) and 6 (18.2%) centres throughout P1 and P2, respectively. In the two phases, about two thirds centres registered positive or suspected cases amongst patients. CONCLUSION: The study revealed a particular attention to anti-contagion measures and a return to normal or even higher clinical workload in most RT centres in Lombardy, necessary to carry out current and previously deferred treatments. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12032-020-01434-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7641253 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-76412532020-11-05 Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 Jereczek-Fossa, Barbara Alicja Pepa, Matteo Marvaso, Giulia Isaksson, Johannes Lars Soatti, Carlo Pietro Cazzaniga, Luigi Franco Ivaldi, Giovanni Battista Amadori, Marcello Antognoni, Paolo Arcangeli, Stefano Buffoli, Alberto Beltramo, Giancarlo Bignardi, Mario Bracelli, Stefano Bruschieri, Lorenza Castiglioni, Simona Catalano, Gianpiero Di Muzio, Nadia Fallai, Carlo Fariselli, Laura Filippi, Andrea Riccardo Gramaglia, Alberto Italia, Corrado Lombardi, Fabrizio Magrini, Stefano Maria Nava, Simonetta Orlandi, Ester Pasinetti, Nadia Sbicego, Elena Lara Scandolaro, Luciano Scorsetti, Marta Stiglich, Francesco Tortini, Roberto Valdagni, Riccardo Vavassori, Vittorio Tonoli, Sandro Palazzi, Mauro Filippo Med Oncol Original Paper BACKGROUND: Italy experienced one of the world’s severest COVID-19 outbreak, with Lombardy being the most afflicted region. However, the imposed safety measures allowed to flatten the epidemic curve and hence to ease the restrictions and inaugurate, on the 4th of May 2020, the Italian phase (P) 2 of the pandemic. The present survey study, endorsed by CODRAL and AIRO-L, aimed to assess how radiotherapy (RT) departments in Lombardy have dealt with the recovery. MATERIALS AND METHODS: A questionnaire dealing with the management of pandemic was developed online and sent to all CODRAL Directors on the 10th of June 2020. Answers were collected in full anonymity one week after. RESULTS: All the 33 contacted RT facilities (100%) responded to the survey. Despite the scale of the pandemic, during P1 14 (42.4%) centres managed to safely continue the activity (≤ 10% reduction). During P2, 10 (30.3%) centres fully recovered and 14 (42.4%) reported an increase. Nonetheless, 6 (18.2%) declared no changes and, interestingly, 3 (9.1%) reduced activities. Overall, 21 centres (63.6%) reported suspected or positive cases within healthcare workforce since the beginning of the pandemic. Staff units were quarantined in 19 (57.6%) and 6 (18.2%) centres throughout P1 and P2, respectively. In the two phases, about two thirds centres registered positive or suspected cases amongst patients. CONCLUSION: The study revealed a particular attention to anti-contagion measures and a return to normal or even higher clinical workload in most RT centres in Lombardy, necessary to carry out current and previously deferred treatments. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12032-020-01434-1) contains supplementary material, which is available to authorized users. Springer US 2020-11-04 2020 /pmc/articles/PMC7641253/ /pubmed/33150476 http://dx.doi.org/10.1007/s12032-020-01434-1 Text en © Springer Science+Business Media, LLC, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Paper Jereczek-Fossa, Barbara Alicja Pepa, Matteo Marvaso, Giulia Isaksson, Johannes Lars Soatti, Carlo Pietro Cazzaniga, Luigi Franco Ivaldi, Giovanni Battista Amadori, Marcello Antognoni, Paolo Arcangeli, Stefano Buffoli, Alberto Beltramo, Giancarlo Bignardi, Mario Bracelli, Stefano Bruschieri, Lorenza Castiglioni, Simona Catalano, Gianpiero Di Muzio, Nadia Fallai, Carlo Fariselli, Laura Filippi, Andrea Riccardo Gramaglia, Alberto Italia, Corrado Lombardi, Fabrizio Magrini, Stefano Maria Nava, Simonetta Orlandi, Ester Pasinetti, Nadia Sbicego, Elena Lara Scandolaro, Luciano Scorsetti, Marta Stiglich, Francesco Tortini, Roberto Valdagni, Riccardo Vavassori, Vittorio Tonoli, Sandro Palazzi, Mauro Filippo Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 |
title | Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 |
title_full | Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 |
title_fullStr | Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 |
title_full_unstemmed | Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 |
title_short | Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 |
title_sort | back to (new) normality—a codral/airo-l survey on cancer radiotherapy in lombardy during italian covid-19 phase 2 |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641253/ https://www.ncbi.nlm.nih.gov/pubmed/33150476 http://dx.doi.org/10.1007/s12032-020-01434-1 |
work_keys_str_mv | AT jereczekfossabarbaraalicja backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT pepamatteo backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT marvasogiulia backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT isakssonjohanneslars backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT soatticarlopietro backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT cazzanigaluigifranco backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT ivaldigiovannibattista backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT amadorimarcello backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT antognonipaolo backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT arcangelistefano backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT buffolialberto backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT beltramogiancarlo backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT bignardimario backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT bracellistefano backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT bruschierilorenza backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT castiglionisimona backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT catalanogianpiero backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT dimuzionadia backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT fallaicarlo backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT farisellilaura backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT filippiandreariccardo backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT gramagliaalberto backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT italiacorrado backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT lombardifabrizio backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT magrinistefanomaria backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT navasimonetta backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT orlandiester backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT pasinettinadia backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT sbicegoelenalara backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT scandolaroluciano backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT scorsettimarta backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT stiglichfrancesco backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT tortiniroberto backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT valdagniriccardo backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT vavassorivittorio backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT tonolisandro backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT palazzimaurofilippo backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 AT backtonewnormalityacodralairolsurveyoncancerradiotherapyinlombardyduringitaliancovid19phase2 |